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Background:  Prosthesis dysfunction, especially paravalvular insufficiency is difficult to quantify with precision and is of increasing 
importance in transcatheter aortic valve replacement (TAVR). Von Willebrand Factor (VWF) activity laboratory measures proportionally 
reflect high shear stress in vivo, and may reflect the severity of paravalvular insufficiency.
methods:  We compared three independent measures of VWF activity to BNP in patients with dysfunctional aortic prostheses (dAVR), 
or dysfunctional mitral valve repair or replacement (dMVR/rep), and contrasted these with normally functioning surgical aortic valve 
replacement or TAVR, and to normally functioning mitral valve replacement or repair.
results:  VWF multimers were abnormal in 10/13 dAVR, but in 0/11 normal mechanical AVR (p=0.0002) and in 1/15 normal tissue 
AVR or TAVR (p=0.0003). Similar results were seen with platelet function analyzer 100 and with VWF activity to antigen ratio (VWF:Act/
VWF:Ag), while differences in BNP were not significant. VWF multimers were abnormal in 12/13 dMVR/rep but only 1/26 normal mitral 
valve replacement (p<0.0001) and 1/13 normally functioning mitral valve repair (p<0.0001). Similar results were seen with platelet function 
analyzer and VWF:Act/VWF:Ag while differences in BNP were not significant. Severe gastrointestinal bleeding was present in 2/13 dAVR 
patients and 5/13 dMVR/rep patients. Patients with prosthesis dysfunction with versus without bleeding were older, median (IQR) 79 (74-
82) years versus 70 (63-76) years (p=0.05), exhibited a trend toward longer duration of implant 7 (3-19) years versus 4 (0.7-11) years 
(p=0.18), but did not have significantly different multimer abnormalities, 7/7 versus 14/19 (p=0.55).
conclusion:  VWF activity testing is distinctly abnormal in patients with dysfunctional aortic prostheses and with dysfunctional mitral 
valve replacement or repair and may be associated with severe bleeding. Tests in this system may be considered as biomarkers of 
prosthesis dysfunction, and severe bleeding associated with dysfunctional valve prosthesis and acquired von Willebrand syndrome may be 
considered as an indication for intervention.
